Access to health-related products, technologies and services<br />David Heymann<br />Head and Senior Fellow, Centre on Glo...
Distribution of deaths by cause and gender, 2004 <br />Source: GBD, WHO 2004<br />
Child mortality rates by cause and region, 2004<br />~ 1 million deaths per year<br />Source: GBD 2004, WHO<br />
Estimated malaria incidence per 1000 population, 2006 <br /> In addition to human suffering and death,<br /> an estimated ...
Effective evidence-based interventions: Malaria<br />	Reduce exposure to mosquitoes <br />	Prompt diagnosis<br />	Prompt t...
Development agencies and health,  before 2000<br />“Medicines not sustainable….the only <br />cost effective interventions...
WHO Commission on Macroeconomics and Health<br />Macroeconomics and Health<br />Commissioners<br />
Access to medicines: The Global Fund, funding 2001 - 2009<br />4<br />3<br />Billions of dollars US<br />2<br />   	US$ 2....
Other contributions to access to medicines and vaccines<br />
The Global Fund: long term sustainability <br />……….<br />Source:  New York Times, May 2010<br />
GAVI: long term sustainability<br />Source:  The Lancet Vol 375:9117. 791, 6 March 2010<br />
Non-communicable diseases<br />
Non-communicable diseases are increasing burden in all countries<br />
Diabetes, a non-communicable disease with high mortality<br />
Cost of care for diabetics, recent estimates<br />
What are the sustainable models for increasing access to medicines, vaccines and other health-related technologies<br />Ac...
Upcoming SlideShare
Loading in …5
×

Launch of Policy Cures: Access to Health-related Products, Technologies and Services - Professor David Heymann, LSHTM and Chatham House

1,130 views
1,053 views

Published on

Professor David Heymann, of the London School of Hygiene and Tropical Medicine and Chatham House, explained the recent history of access to health-related products and services and the challenges ahead at the launch of Policy Cures on 16 September 2010. In his presentation he highlighted the cost of malaria – estimated at $12 billion per year –and how the donor community has shifted from the pursuit of a vaccine to providing medicines.

Published in: Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,130
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Launch of Policy Cures: Access to Health-related Products, Technologies and Services - Professor David Heymann, LSHTM and Chatham House

  1. 1. Access to health-related products, technologies and services<br />David Heymann<br />Head and Senior Fellow, Centre on Global Health Security, Chatham House<br />Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine<br />
  2. 2. Distribution of deaths by cause and gender, 2004 <br />Source: GBD, WHO 2004<br />
  3. 3. Child mortality rates by cause and region, 2004<br />~ 1 million deaths per year<br />Source: GBD 2004, WHO<br />
  4. 4. Estimated malaria incidence per 1000 population, 2006 <br /> In addition to human suffering and death,<br /> an estimated US$ 12 billion lost each year<br /> from direct and indirect costs<br />Source: World Malaria Report, 2008<br />
  5. 5. Effective evidence-based interventions: Malaria<br /> Reduce exposure to mosquitoes <br /> Prompt diagnosis<br /> Prompt treatment in children, <br /> and intermittent treatment in pregnant women<br />Source: WHO<br />
  6. 6. Development agencies and health, before 2000<br />“Medicines not sustainable….the only <br />cost effective interventions are vaccines”<br />
  7. 7. WHO Commission on Macroeconomics and Health<br />Macroeconomics and Health<br />Commissioners<br />
  8. 8. Access to medicines: The Global Fund, funding 2001 - 2009<br />4<br />3<br />Billions of dollars US<br />2<br /> US$ 2.6 billion to malaria programmes in 85 countries<br />1<br />0<br />2001-<br />2006<br />2008<br />2005<br />2007<br />2009<br />Year<br />2004<br />
  9. 9. Other contributions to access to medicines and vaccines<br />
  10. 10. The Global Fund: long term sustainability <br />……….<br />Source: New York Times, May 2010<br />
  11. 11. GAVI: long term sustainability<br />Source: The Lancet Vol 375:9117. 791, 6 March 2010<br />
  12. 12. Non-communicable diseases<br />
  13. 13. Non-communicable diseases are increasing burden in all countries<br />
  14. 14. Diabetes, a non-communicable disease with high mortality<br />
  15. 15. Cost of care for diabetics, recent estimates<br />
  16. 16. What are the sustainable models for increasing access to medicines, vaccines and other health-related technologies<br />Access to health-related products, technologies and services<br />

×